Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial).
Tripathi D, Patch D, Mehrzad H, Yu D, Aspinall RJ, Armstrong MJ, Stanley A, Ireland H, Travis S, Hayes P, Lomax M, Roslund N, Lam E, Slinn G, Jowett S, Moakes C, Maher A, Brettell E, Sehmi S; REACT-AVB trial collaborative group. Tripathi D, et al. Among authors: hayes p. BMJ Open Gastroenterol. 2024 Mar 22;11(1):e001314. doi: 10.1136/bmjgast-2023-001314. BMJ Open Gastroenterol. 2024. PMID: 38519049 Free PMC article.
Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial.
Rowe IA, Villanueva C, Shearer JE, Torres F, Albillos A, Genescà J, Garcia-Pagan JC, Tripathi D, Hayes PC, Bosch J, Abraldes JG; PREDESCI trial investigators. Rowe IA, et al. Hepatology. 2023 Aug 1;78(2):530-539. doi: 10.1097/HEP.0000000000000342. Epub 2023 Mar 13. Hepatology. 2023. PMID: 36897269 Clinical Trial.
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Manousou P, Cholongitas E, Samonakis D, Tsochatzis E, Corbani A, Dhillon AP, Davidson J, Rodríguez-Perálvarez M, Patch D, O'Beirne J, Thorburn D, Luong T, Rolles K, Davidson B, McCormick PA, Hayes P, Burroughs AK. Manousou P, et al. Among authors: hayes p. Gut. 2014 Jun;63(6):1005-13. doi: 10.1136/gutjnl-2013-305606. Epub 2013 Oct 16. Gut. 2014. PMID: 24131637 Free PMC article. Clinical Trial.
Carvedilol--A new nonselective beta blocker.
Forrest E, Stanley A, Hayes P. Forrest E, et al. Among authors: hayes p. Hepatology. 2000 Mar;31(3):809-11. doi: 10.1002/hep.510310341. Hepatology. 2000. PMID: 10722317 No abstract available.
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.
Innes HA, Hutchinson SJ, Allen S, Bhattacharyya D, Bramley P, Carman B, Delahooke TE, Dillon JF, Goldberg DJ, Kennedy N, Mills PR, Morris J, Morris J, Robertson C, Stanley AJ, Hayes P; Hepatitis C Clinical Database Monitoring Committee. Innes HA, et al. Among authors: hayes p. Eur J Gastroenterol Hepatol. 2012 Jun;24(6):646-55. doi: 10.1097/MEG.0b013e32835201a4. Eur J Gastroenterol Hepatol. 2012. PMID: 22433796 Review.
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population.
Innes H, McDonald S, Hayes P, Dillon JF, Allen S, Goldberg D, Mills PR, Barclay ST, Wilks D, Valerio H, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley A, Bramley P, Hutchinson SJ. Innes H, et al. Among authors: hayes p. J Hepatol. 2017 Jan;66(1):19-27. doi: 10.1016/j.jhep.2016.08.004. Epub 2016 Aug 18. J Hepatol. 2017. PMID: 27545496
1,432 results